WallStreetZenWallStreetZen

NASDAQ: SYBX
Synlogic Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$1.06+0.00 (+0%)
Updated Apr 21, 2025
SYBX Price
$1.06
Fair Value Price
$1.51
Market Cap
$12.40M
52 Week Low
$0.90
52 Week High
$1.96
P/E
-0.55x
P/B
0.97x
P/S
2,134.34x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.00k
Earnings
-$23.36M
Gross Margin
100%
Operating Margin
-291,925%
Profit Margin
-291,987.5%
Debt to Equity
0.56
Operating Cash Flow
-$32M
Beta
0.9
Next Earnings
May 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

SYBX Overview

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SYBX's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
SYBX
RankedUnranked of 462

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Protalix Biotherapeutics (PLX)
$2.55A
Aurinia Pharmaceuticals (AUPH)
$7.66A
Catalyst Pharmaceuticals (CPRX)
$22.02A
View Top Biotech Stocks

Be the first to know about important SYBX news, forecast changes, insider trades & much more!

SYBX News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SYBX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SYBX ($1.06) is undervalued by 29.76% relative to our estimate of its Fair Value price of $1.51 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SYBX ($1.06) is significantly undervalued by 29.76% relative to our estimate of its Fair Value price of $1.51 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SYBX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SYBX due diligence checks available for Premium users.

Valuation

SYBX fair value

Fair Value of SYBX stock based on Discounted Cash Flow (DCF)

Price
$1.06
Fair Value
$1.51
Undervalued by
29.76%
SYBX ($1.06) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SYBX ($1.06) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SYBX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SYBX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.55x
Industry
-184.27x
Market
27.14x

SYBX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.97x
Industry
4.04x
SYBX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SYBX's financial health

Profit margin

Revenue
$0.0
Net Income
-$714.0k
Profit Margin
0%
SYBX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SYBX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$19.8M
Liabilities
$7.1M
Debt to equity
0.56
SYBX's short-term assets ($19.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SYBX's short-term assets ($19.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SYBX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SYBX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$568.0k
Investing
$30.0k
Financing
$9.0k
SYBX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SYBX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SYBX–$12.40M0.00%-0.55x0.97x
CLDI–$12.53M-4.97%-0.15x8.17x
MEIP–$12.73M-2.85%-0.33x0.58x
ABP–$12.06M-10.47%-0.31x-0.78x
BRTX–$12.83M-2.29%-1.47x1.50x
View Top Biotech Stocks

Synlogic Stock FAQ

What is Synlogic's quote symbol?

(NASDAQ: SYBX) Synlogic trades on the NASDAQ under the ticker symbol SYBX. Synlogic stock quotes can also be displayed as NASDAQ: SYBX.

If you're new to stock investing, here's how to buy Synlogic stock.

What is the 52 week high and low for Synlogic (NASDAQ: SYBX)?

(NASDAQ: SYBX) Synlogic's 52-week high was $1.96, and its 52-week low was $0.90. It is currently -45.92% from its 52-week high and 18.04% from its 52-week low.

How much is Synlogic stock worth today?

(NASDAQ: SYBX) Synlogic currently has 11,696,109 outstanding shares. With Synlogic stock trading at $1.06 per share, the total value of Synlogic stock (market capitalization) is $12.40M.

Synlogic stock was originally listed at a price of $740.25 in Oct 1, 2015. If you had invested in Synlogic stock at $740.25, your return over the last 9 years would have been -99.86%, for an annualized return of -51.7% (not including any dividends or dividend reinvestments).

How much is Synlogic's stock price per share?

(NASDAQ: SYBX) Synlogic stock price per share is $1.06 today (as of Apr 21, 2025).

What is Synlogic's Market Cap?

(NASDAQ: SYBX) Synlogic's market cap is $12.40M, as of Apr 22, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Synlogic's market cap is calculated by multiplying SYBX's current stock price of $1.06 by SYBX's total outstanding shares of 11,696,109.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.